Biomarkers of Oxidative Stress for Neonatal Lung Disease

The transition from prenatal to postnatal life causes a significant increase in arterial oxygen tension and the activation of metabolic pathways enabling the newborn's adaptation to the extra-uterine environment. The balance between pro-oxidant and anti-oxidant systems is critical to preserve c...

Full description

Bibliographic Details
Main Authors: Giuliana Ferrante, Giuseppe Carota, Giovanni Li Volti, Mario Giuffrè
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.618867/full
id doaj-ce46d1cdf2824ee18c407fa2192c60ae
record_format Article
spelling doaj-ce46d1cdf2824ee18c407fa2192c60ae2021-02-18T05:10:47ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602021-02-01910.3389/fped.2021.618867618867Biomarkers of Oxidative Stress for Neonatal Lung DiseaseGiuliana Ferrante0Giuseppe Carota1Giovanni Li Volti2Mario Giuffrè3Dipartimento di Promozione della Salute, Materno-Infantile, Medicina Interna e Specialistica d'Eccellenza “G. D'Alessandro”, Università degli Studi di Palermo, Palermo, ItalyDipartimento di Scienze Biomediche e Biotecnologiche, Università degli Studi di Catania, Catania, ItalyDipartimento di Scienze Biomediche e Biotecnologiche, Università degli Studi di Catania, Catania, ItalyDipartimento di Promozione della Salute, Materno-Infantile, Medicina Interna e Specialistica d'Eccellenza “G. D'Alessandro”, Università degli Studi di Palermo, Palermo, ItalyThe transition from prenatal to postnatal life causes a significant increase in arterial oxygen tension and the activation of metabolic pathways enabling the newborn's adaptation to the extra-uterine environment. The balance between pro-oxidant and anti-oxidant systems is critical to preserve cellular functions. Indeed, oxidative stress (OS) occurs when the production of free radicals is not balanced by the activity of intracellular antioxidant systems, contributing to cellular and tissue damage. Perinatal OS may have serious health consequences during the postnatal period and later in life. Namely, OS has been recognized as the major cause of lung injury in newborns, especially those preterm born, due to their immature lung and antioxidant systems. The development of OS biomarkers has gained increasing research interest since they may provide useful insights about pathophysiological pathways underlying OS-mediated pulmonary diseases in newborns. Moreover, their implementation in clinical settings may help to early identify high risk-newborns and to provide targeted treatment. Ideally, a biomarker should demonstrate ease of use, biological validity and reproducibility, high sensitivity and specificity. However, none of the clinically validated biomarkers so far have been qualified for neonatal lung disease. Additionally, the complex technical procedures and the high cost of such determinations have hampered the use of OS biomarkers in clinical practice. This review aims to evaluate the current evidence on the application of biomarkers of oxidative stress for neonatal lung disease and exploring the most relevant issues affecting their implementation in practice, as well as the associated evidence gaps and research limitations.https://www.frontiersin.org/articles/10.3389/fped.2021.618867/fulloxidative stressbiomarkerlung diseasenewbornprematurity
collection DOAJ
language English
format Article
sources DOAJ
author Giuliana Ferrante
Giuseppe Carota
Giovanni Li Volti
Mario Giuffrè
spellingShingle Giuliana Ferrante
Giuseppe Carota
Giovanni Li Volti
Mario Giuffrè
Biomarkers of Oxidative Stress for Neonatal Lung Disease
Frontiers in Pediatrics
oxidative stress
biomarker
lung disease
newborn
prematurity
author_facet Giuliana Ferrante
Giuseppe Carota
Giovanni Li Volti
Mario Giuffrè
author_sort Giuliana Ferrante
title Biomarkers of Oxidative Stress for Neonatal Lung Disease
title_short Biomarkers of Oxidative Stress for Neonatal Lung Disease
title_full Biomarkers of Oxidative Stress for Neonatal Lung Disease
title_fullStr Biomarkers of Oxidative Stress for Neonatal Lung Disease
title_full_unstemmed Biomarkers of Oxidative Stress for Neonatal Lung Disease
title_sort biomarkers of oxidative stress for neonatal lung disease
publisher Frontiers Media S.A.
series Frontiers in Pediatrics
issn 2296-2360
publishDate 2021-02-01
description The transition from prenatal to postnatal life causes a significant increase in arterial oxygen tension and the activation of metabolic pathways enabling the newborn's adaptation to the extra-uterine environment. The balance between pro-oxidant and anti-oxidant systems is critical to preserve cellular functions. Indeed, oxidative stress (OS) occurs when the production of free radicals is not balanced by the activity of intracellular antioxidant systems, contributing to cellular and tissue damage. Perinatal OS may have serious health consequences during the postnatal period and later in life. Namely, OS has been recognized as the major cause of lung injury in newborns, especially those preterm born, due to their immature lung and antioxidant systems. The development of OS biomarkers has gained increasing research interest since they may provide useful insights about pathophysiological pathways underlying OS-mediated pulmonary diseases in newborns. Moreover, their implementation in clinical settings may help to early identify high risk-newborns and to provide targeted treatment. Ideally, a biomarker should demonstrate ease of use, biological validity and reproducibility, high sensitivity and specificity. However, none of the clinically validated biomarkers so far have been qualified for neonatal lung disease. Additionally, the complex technical procedures and the high cost of such determinations have hampered the use of OS biomarkers in clinical practice. This review aims to evaluate the current evidence on the application of biomarkers of oxidative stress for neonatal lung disease and exploring the most relevant issues affecting their implementation in practice, as well as the associated evidence gaps and research limitations.
topic oxidative stress
biomarker
lung disease
newborn
prematurity
url https://www.frontiersin.org/articles/10.3389/fped.2021.618867/full
work_keys_str_mv AT giulianaferrante biomarkersofoxidativestressforneonatallungdisease
AT giuseppecarota biomarkersofoxidativestressforneonatallungdisease
AT giovannilivolti biomarkersofoxidativestressforneonatallungdisease
AT mariogiuffre biomarkersofoxidativestressforneonatallungdisease
_version_ 1724263948683837440